Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Acq. announced
CC transcript
Inv. presentation

SALIX PHARMACEUTICALS LTD (SLXP) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/30/2015 8-K/A Regulation FD Disclosure, Financial Statements and Exhibits
07/16/2014 8-K/A Other Events, Financial Statements and Exhibits
Docs: "FDA Office of Drug Evaluation III Approves Salix's Request that the FDA Approve the RELISTOR ® Subcutaneous Injection sNDA for the Treatment of Opioid-induced Constipation in Patients with Chronic Non-cancer Pain"
02/28/2012 8-K/A Financial Statements and Exhibits
Docs: "Consent of Independent Registered Public Accounting Firm",
"Audited Consolidated Financial Statements of Oceana Therapeutics, Inc. as of and for the years ended December 31, 2010 and 2009",
"Unaudited Consolidated Financial Statements of Oceana Therapeutics, Inc. as of and for the nine months ended September 30, 2011 and 2010"
03/26/2009 8-K/A Form 8-K/A -- Current report [amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy